AN-2728
CAS No. 906673-24-3
AN-2728 ( Crisaborole;AN2728;AN 2728 )
Catalog No. M16514 CAS No. 906673-24-3
A potent PDE4 inhibitor with IC50 of 0.49 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 34 | In Stock |
|
50MG | 45 | In Stock |
|
100MG | 75 | In Stock |
|
200MG | 100 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAN-2728
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent PDE4 inhibitor with IC50 of 0.49 uM.
-
DescriptionA potent PDE4 inhibitor with IC50 of 0.49 uM; also shows inhibition against PDE1A3, PDE3Cat, and PDE7A1; suppresses the release of TNFalpha, IL-12, IL-23 and other cytokines.Dermatitis Phase 2 Clinical
-
SynonymsCrisaborole;AN2728;AN 2728
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE4
-
Research AreaInflammation/Immunology
-
IndicationDermatitis
Chemical Information
-
CAS Number906673-24-3
-
Formula Weight251.05
-
Molecular FormulaC14H10BNO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 32 mg/mL
-
SMILESN#CC1=CC=C(OC2=CC=C3C(B(O)OC3)=C2)C=C1
-
Chemical NameBenzonitrile, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Akama T, et al. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2129-32.
2. Nazarian R, et al. Curr Opin Investig Drugs. 2009 Nov;10(11):1236-42.
3. Freund YR, et al. FEBS Lett. 2012 Sep 21;586(19):3410-4.
2. Nazarian R, et al. Curr Opin Investig Drugs. 2009 Nov;10(11):1236-42.
3. Freund YR, et al. FEBS Lett. 2012 Sep 21;586(19):3410-4.
molnova catalog
related products
-
Lotamilast
Lotamilast (RVT 501, E6005) is apotent, selective PDE4 inhibitor with IC50 of 2.8 nM, suppresses the production of various cytokines from human lymphocytes and monocytes with IC50 of 0.49-3.1 nM.
-
ITI214
ITI-214 is a potent, selective, orally active phosphodiesterase 1 (PDE1) inhibitor with Ki of 58 pM.
-
TAK-063
TAK-063 (Balipodect) is a highly potent, selective, orally active PDE10A inhibitor with IC50 of 0.3 nM.